Circulating Neutrophils of Nonalcoholic Steatohepatitis Patients Show an Activated Phenotype and Suppress T Lymphocytes Activity

Circulating Neutrophils of Nonalcoholic Steatohepatitis Patients Show an Activated Phenotype and Suppress T Lymphocytes Activity

Neutrophils or PolyMorphonuclear Neutrophils (PMNs) are key effector cells of the innate immune system and thanks to their remarkable plasticity, establish a cross talk with T cells modulating their survival and effector functions. During Nonalcoholic Steatohepatitis (NASH), the advanced form of hep...

Full description

Bibliographic Details
Main Authors:	Laura Antonucci, Cristiana Porcu, Eleonora Timperi, Silvano Junior Santini, Gino Iannucci, Clara Balsano
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2020/4570219

Similar Items

Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper
by: Laura Antonucci, et al.
Published: (2017-10-01)

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
by: Seonghwan Hwang, et al.
Published: (2021-10-01)

Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis
by: Monica A. Tincopa
Published: (2020-10-01)

Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis
by: Yongyan Chen, et al.
Published: (2020-07-01)

Complement alternative pathway activation in human nonalcoholic steatohepatitis.
by: Filip M Segers, et al.
Published: (2014-01-01)

Necroptosis in Nonalcoholic Steatohepatitis
by: Jérémie Gautheron, PhD, et al.
Published: (2015-05-01)

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
by: Tae Hyung Kim, et al.
Published: (2021-07-01)

Nonalcoholic Steatohepatitis: An Evolving Diagnosis
by: Brent A Neuschwander-Tetri
Published: (2000-01-01)

The metabolic basis of nonalcoholic steatohepatitis
by: Manu V. Chakravarthy, et al.
Published: (2020-10-01)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
by: Gopanandan Parthasarathy, et al.
Published: (2020-04-01)

Liver Fibrogenesis in Nonalcoholic Steatohepatitis
by: Xiong eMa
Published: (2012-07-01)

Recent update: Nonalcoholic steatohepatitis
by: Vivek Hande, et al.
Published: (2018-01-01)

HISTOPATOLOGICAL ASPECTS IN NONALCOHOLIC STEATOHEPATITIS
by: Anca-Mirela Pasparan, et al.
Published: (2008-02-01)

IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
by: Anca Smaranda Farmazon, et al.
Published: (2018-09-01)

The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated with Specific Changes in Circulating Bile Acids
by: Aline Gottlieb, et al.
Published: (2018-05-01)

Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis ProgressionSummary
by: Kuo Du, et al.
Published: (2020-01-01)

Oleuropein overrides liver damage in steatotic mice
by: Silvano Junior Santini, et al.
Published: (2020-02-01)

A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis
by: Jie Liu, et al.
Published: (2018-03-01)

Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism
by: Beatriz Villar, et al.
Published: (2021-06-01)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
by: Koichiro Wada, et al.
Published: (2013-11-01)

Human Nonalcoholic Steatohepatitis on a Chip
by: May S. Freag, et al.
Published: (2021-02-01)

The regulatory state of nonalcoholic steatohepatitis and metabolism
by: Stephanie O. Omokaro, et al.
Published: (2020-10-01)

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis
by: Yoshio Sumida, et al.
Published: (2020-03-01)

Value of microparticles in the diagnosis of nonalcoholic steatohepatitis
by: CHEN Jun
Published: (2019-09-01)

Uncovered issues in the overview of nonalcoholic steatohepatitis
by: Chia-Chi Wang
Published: (2011-12-01)

Macrophages in Nonalcoholic Steatohepatitis: Friend or Foe?
by: Joel Grunhut, et al.
Published: (2018-05-01)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
by: Mindy C.W. Lam, et al.
Published: (2012-07-01)

Nonalcoholic Steatohepatitis in Nondiabetic Obese Patients
by: Idilio Zamin, et al.
Published: (2002-01-01)

New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
by: Nahum Mendez-Sanchez, et al.
Published: (2018-07-01)

Lipoprotein subclass metabolism in nonalcoholic steatohepatitis[S]
by: Ville T. Männistö, et al.
Published: (2014-12-01)

Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis
by: S.M. Touhidul Islam, et al.
Published: (2020-09-01)

In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice
by: Li, Hui, et al.
Published: (2017)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Ji-Young Cha, et al.
Published: (2018-12-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01)

Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
by: Sebastião M.B. Duarte, et al.
Published: (2019-05-01)

Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
by: Mazen Noureddin, et al.
Published: (2020-10-01)

Nature or Nurture? The Answer Is “Both” in Nonalcoholic Steatohepatitis
by: Rotonya M. Carr, MD
Published: (2020-01-01)

Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology
by: In Cheol Yoon, et al.
Published: (2019-05-01)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
by: Helma P. Cotrim, et al.
Published: (2016-05-01)

A Microphysiological System for Studying Nonalcoholic Steatohepatitis
by: Tomasz Kostrzewski, et al.
Published: (2020-01-01)